Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DR26F7TS8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,663
Award facts
- Contract value 100% obligated
- $16,663.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,663.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kisqali 400 mg daily dose tablets (42-count packaging) with a completion date of November 28, 2025. This non-set-aside competitive award was issued on November 5, 2025, to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies to military and veteran healthcare systems. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products globally.
This delivery order represents a routine replenishment transaction within AmerisourceBergen's expansive federal pharmaceutical supply portfolio with the Defense Logistics Agency. The company's DLA Troop Support Medical IDC serves as the primary vehicle for distributing specialty medications, brand-name and generic pharmaceuticals, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The Kisqali medication delivery supports oncology treatment needs within the federal healthcare system's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7TS8?
SPE2DR26F7TS8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F7TS8 worth?
The government has obligated $16,663 on SPE2DR26F7TS8.
Is contract SPE2DR26F7TS8 an order under another contract?
Yes. SPE2DR26F7TS8 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7TS8 competed?
The extent of competition for SPE2DR26F7TS8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award